Janney Montgomery Scott’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $65.5M | Buy |
2,334,351
+118,964
| +5% | +$3.17M | 0.16% | 137 |
|
|
2025
Q4 | $55.2M | Buy |
2,215,387
+199,213
| +10% | +$5.02M | 0.13% | 168 |
|
|
2025
Q3 | $51.4M | Buy |
+2,016,174
| New | +$49.8M | 0.12% | 165 |
|
|
2025
Q1 | – | Sell |
-2,453,989
| Closed | -$65.1M | – | 2823 |
|
|
2024
Q4 | $65.1M | Sell |
2,453,989
-366,688
| -13% | -$9.95M | 0.18% | 115 |
|
|
2024
Q3 | $81.6M | Buy |
2,820,677
+143,347
| +5% | +$4.18M | 0.23% | 88 |
|
|
2024
Q2 | $74.9M | Buy |
2,677,330
+163,017
| +6% | +$4.49M | 0.23% | 90 |
|
|
2024
Q1 | $69.8M | Buy |
2,514,313
+28,797
| +1% | +$799K | 0.21% | 98 |
|
|
2023
Q4 | $71.6M | Sell |
2,485,516
-128,149
| -5% | -$3.87M | 0.23% | 91 |
|
|
2023
Q3 | $86.7M | Sell |
2,613,665
-96,723
| -4% | -$3.42M | 0.32% | 62 |
|
|
2023
Q2 | $99.4M | Buy |
2,710,388
+47,807
| +2% | +$1.86M | 0.35% | 65 |
|
|
2023
Q1 | $109M | Sell |
2,662,581
-14,465
| -0.5% | -$625K | 0.44% | 51 |
|
|
2022
Q4 | $137M | Buy |
2,677,046
+87,860
| +3% | +$4.21M | 0.53% | 35 |
|
|
2022
Q3 | $113M | Buy |
2,589,186
+79,364
| +3% | +$3.86M | 0.49% | 38 |
|
|
2022
Q2 | $128M | Buy |
2,509,822
+51,923
| +2% | +$2.65M | 0.58% | 29 |
|
|
2022
Q1 | $127M | Buy |
2,457,899
+54,633
| +2% | +$2.83M | 0.54% | 36 |
|
|
2021
Q4 | $142M | Buy |
2,403,266
+48,473
| +2% | +$2.4M | 0.55% | 32 |
|
|
2021
Q3 | $101M | Buy |
2,354,793
+1,592
| +0.1% | +$70.5K | 0.43% | 51 |
|
|
2021
Q2 | $92.2M | Sell |
2,353,201
-66,485
| -3% | -$2.59M | 0.41% | 56 |
|
|
2021
Q1 | $87.7M | Buy |
2,419,686
+23,669
| +1% | +$840K | 0.43% | 55 |
|
|
2020
Q4 | $88.2M | Buy |
2,396,017
+36,230
| +2% | +$1.33M | 0.43% | 52 |
|
|
2020
Q3 | $82.2M | Buy |
2,359,787
+11,520
| +0.5% | +$404K | 0.47% | 46 |
|
|
2020
Q2 | $72.9M | Sell |
2,348,267
-169,738
| -7% | -$5.77M | 0.46% | 49 |
|
|
2020
Q1 | $78M | Buy |
2,518,005
+187,053
| +8% | +$6.37M | 0.62% | 29 |
|
|
2019
Q4 | $86.6M | Buy |
2,330,952
+121,657
| +6% | +$4.33M | 0.57% | 32 |
|
|
2019
Q3 | $75.3M | Buy |
2,209,295
+73,891
| +3% | +$2.69M | 0.55% | 36 |
|
|
2019
Q2 | $87.8M | Buy |
2,135,404
+101,582
| +5% | +$4.03M | 0.67% | 21 |
|
|
2019
Q1 | $82M | Buy |
2,033,822
+35,634
| +2% | +$1.43M | 0.67% | 20 |
|
|
2018
Q4 | $82.8M | Sell |
1,998,188
-126,206
| -6% | -$5.24M | 0.8% | 17 |
|
|
2018
Q3 | $88.8M | Sell |
2,124,394
-1,739
| -0.1% | -$66.9K | 0.76% | 16 |
|
|
2018
Q2 | $73.2M | Sell |
2,126,133
-65,870
| -3% | -$2.25M | 0.7% | 19 |
|
|
2018
Q1 | $73.8M | Buy |
2,192,003
+165,996
| +8% | +$5.71M | 0.74% | 17 |
|
|
2017
Q4 | $69.6M | Buy |
2,026,007
+78,272
| +4% | +$2.67M | 0.72% | 17 |
|
|
2017
Q3 | $66M | Buy |
1,947,735
+48,531
| +3% | +$1.56M | 0.75% | 17 |
|
|
2017
Q2 | $60.5M | Buy |
1,899,204
+1,032
| +0.1% | +$32.5K | 0.76% | 18 |
|
|
2017
Q1 | $61.6M | Buy |
1,898,172
+195,681
| +11% | +$6.17M | 0.82% | 14 |
|
|
2016
Q4 | $52.5M | Buy |
1,702,491
+288,309
| +20% | +$8.8M | 0.79% | 18 |
|
|
2016
Q3 | $45.4M | Sell |
1,414,182
-1,257,240
| -47% | -$42M | 0.8% | 18 |
|
|
2016
Q2 | $89.2M | Buy |
2,671,422
+1,516,571
| +131% | +$48.4M | 1.82% | 7 |
|
|
2016
Q1 | $32.5M | Buy |
1,154,851
+138,999
| +14% | +$3.97M | 0.85% | 20 |
|
|
2015
Q4 | $31.1M | Buy |
1,015,852
+94,190
| +10% | +$2.96M | 0.8% | 18 |
|
|
2015
Q3 | $27.5M | Buy |
921,662
+26,282
| +3% | +$843K | 0.78% | 20 |
|
|
2015
Q2 | $28.5M | Buy |
895,380
+40,216
| +5% | +$1.31M | 0.6% | 23 |
|
|
2015
Q1 | $28.2M | Buy |
855,164
+42,057
| +5% | +$1.34M | 0.53% | 19 |
|
|
2014
Q4 | $24M | Buy |
813,107
+24,990
| +3% | +$717K | 0.48% | 24 |
|
|
2014
Q3 | $22.1M | Buy |
788,117
+71,174
| +10% | +$2M | 0.46% | 24 |
|
|
2014
Q2 | $20.2M | Buy |
716,943
+549
| +0.1% | +$15.7K | 0.44% | 27 |
|
|
2014
Q1 | $21.8M | Buy |
716,394
+115,324
| +19% | +$3.44M | 0.53% | 24 |
|
|
2013
Q4 | $17.5M | Buy |
601,070
+22,320
| +4% | +$650K | 0.46% | 27 |
|
|
2013
Q3 | $15.8M | Buy |
578,750
+265,167
| +85% | +$7.21M | 0.47% | 28 |
|
|
2013
Q2 | $8.33M | Buy |
+313,583
| New | +$8.66M | 0.87% | 15 |
|
Other funds holding PFE
VCM
VPM
Janney Montgomery Scott's PFE Position: Q1 2026 in Review
Janney Montgomery Scott increased its Pfizer (PFE) stake by 5.4% in Q1 2026, buying an estimated $3.17M and bringing the position to 2,334,351 shares worth $65.5M. The position accounts for 0.16% of the portfolio, ranked #137.
Janney Montgomery Scott first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. The position peaked at $142M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Janney Montgomery Scott held 2,334,351 shares of Pfizer worth $65.5M as of Q1 2026.
- Janney Montgomery Scott bought 118,964 Pfizer shares in Q1 2026, an estimated $3.17M.
- Pfizer made up 0.16% of Janney Montgomery Scott's portfolio in Q1 2026, its #137 holding.
- Janney Montgomery Scott first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
- Janney Montgomery Scott's Pfizer position peaked at $142M in Q4 2021.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.